OTC : CPHRF

Cipher Pharmaceuticals Inc.

$11.71 USD

$0.09 (0.77%)

Volume
100
Average Volume
3.7K
Market Capitalization
$297.33M
P/E Ratio
9.44
Dividend Yield
0.00%
Price Target
Year High
$15.00
Year Low
$8.64
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.25
Company Overview

OTC

Craig J. Mull

Drug Manufacturers - Specialty & Generic

Healthcare

CPHRF

6

CA

USD

https://www.cipherpharma.com

905-602-5840

17253X105

N/A

Liquidity Metrics

0.00

1.25

0.85

0.31

0.00

Sales & Valuation

$51.33M

5.75

2.19

9.76

1.19

Profitability

$1.07

$27.81M

60.82%

39.70%

25.69%

20.19%

P/E Metrics

9.44

0.04

0.04

Analyst Price Target & Rating

Strong Buy

5/5

1 Analysts

%

Financial Health Scores

10.32

6/9

$5.15M

$153.78M

$20.6M

$17.94M

Key Metrics (TTM)

$290.44M

5.70

11.56

1.25

25.69%

14.81%

10.49%

10.12%

$12.03

118 days

Company Executives
Name Title
Craig J. Mull Interim Chief Executive Officer & Chairman of the Board
Emilio Presti Director of Sales & Marketing
Bryan Jacobs President
Ryan Mailling Chief Financial Officer
Shengnan Guo Corporate Controller
Poll Results

No votes yet today — be the first to share your view!

About Cipher Pharmaceuticals Inc. (OTC:CPHRF) Stock

Cipher Pharmaceuticals Inc. functions as a specialized pharmaceutical company based in Canada. The firm markets a diverse portfolio of therapies, including Epuris (CIP-ISOTRETINOIN), an isotretinoin formulation specifically developed for addressing severe acne; Ozenoxacin, prescribed for the management of impetigo in both adult and pediatric populations; Actikerall, indicated for treating palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a prescription cream designed to diminish unwanted facial hair growth in women; BRINAVESS, a treatment aimed at restoring sinus rhythm in adults; and AGGRASTAT, an anti-platelet medication administered intravenously. Furthermore, Cipher holds licenses for several products, which encompass CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), a ... fenofibrate-based formulation used to treat hyperlipidemia, a disorder characterized by high cholesterol; and Conzip/Durela (CIP-Tramadol), a tramadol formulation intended for alleviating moderate to moderately severe pain. Looking ahead, the company's development pipeline features several innovative compounds: Trevyent, a vasodilatory prostacyclin analogue targeting pulmonary arterial hypertension; CF-101, which is being explored for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical terbinafine formulation for the treatment of onychomycosis; and DTR-001, a cream under development for tattoo removal. Cipher Pharmaceuticals Inc. was established in the year 2000, with its primary operations located in Oakville, Canada.

Cipher Pharmaceuticals Inc. (CPH:CA) Q1 2026 Earnings Call Transcript

2026-05-08 10:21:16

Cipher Pharmaceuticals Inc. (CPH:CA) Q1 2026 Earnings Call Transcript

Frequently Asked Questions

What is the current Cipher Pharmaceuticals Inc. (CPHRF) stock price?

Cipher Pharmaceuticals Inc.(OTC:CPHRF) stock price is $11.71 in the last trading session. During the trading session, CPHRF stock reached the peak price of $15 while $8.64 was the lowest point it dropped to. The percentage change in CPHRF stock occurred in the recent session was 0.77% while the dollar amount for the price change in CPHRF stock was $0.09.

CPHRF's industry and sector of operation?

The OTC listed CPHRF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of CPHRF?

Craig J. Mull | Interim Chief Executive Officer & Chairman of the Board
Emilio Presti | Director of Sales & Marketing
Bryan Jacobs | President
Ryan Mailling | Chief Financial Officer
Shengnan Guo | Corporate Controller

How many employees does CPHRF have?

Number of CPHRF employees currently stands at 6. CPHRF operates from 5750 Explorer Drive, Mississauga, ON L4W 0A9, CA.

Link for CPHRF official website?

Official Website of CPHRF is: https://www.cipherpharma.com

How do I contact CPHRF?

CPHRF could be contacted at phone #905-602-5840 and can also be accessed through its website. CPHRF operates from 5750 Explorer Drive, Mississauga, ON L4W 0A9, CA.

How many shares of CPHRF are traded daily?

The average number of CPHRF shares traded daily for last 3 months was 3.7K.

What is the market cap of CPHRF currently?

The market value of CPHRF currently stands at $297.33M with its latest stock price at $11.71